Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

Marzinke, Mark A; Hanscom, Brett; Wang, Zhe; Safren, Steven A; Psaros, Christina; Donnell, Deborah; Richardson, Paul A; Sullivan, Philip; Eshleman, Susan H; Jennings, Andrea; Feliciano, Kailazarid Gomez; Jalil, Emilia; Coutinho, Carolina; Cardozo, Nadir; Maia, Bernardo; Khan, Taimur; Singh, Yashna; Middelkoop, Keren; Franks, Julie; Valencia, Javier; Sanchez, Naiymah; Lucas, Jonathan; Rooney, James F; Rinehart, Alex R; Ford, Susan; Adeyeye, Adeola; Cohen, Myron S; McCauley, Marybeth; Landovitz, Raphael J; Grinsztejn, Beatriz; Chariyalertsak, Suwat; Ungsedhapand, Chaiwat; Phanuphak, Nittaya; Ha, Tran Viet; Figueroa, María Inés; Losso, Marcelo H.; Kallas, Esper G.; Valdez Madruga, José; Riegel Santos, Breno; Grinsztejn, Beatriz; Boyer, Juan Carlos Hinojosa; Aguirre, Milagros Erika Matta; Gallardo-Cartagena, Jorge A; Valencia, Javier; Ramirez, Yvett Pinedo; Middelkoop, Keren; Goepfert, Paul; Hosek, Sybil; Liu, Albert; Justman, Jessica; Hurt, Christopher; Reirden, Daniel; Fichtenbaum, Carl; Hall, Christopher; Mayer, Kenneth; Magnus, Manya; van Dam, Cornelius; Franks, Julie; Kelley, Colleen; Arduino, Roberto C.; Rompalo, Anne; Swaminathan, Shobha; Abdalian, Sue Ellen; Van Tieu, Hong; Bazan, Jose; Frank, Ian; del Rio, Carlos; Gaur, Aditya; Landovitz, Raphael J.; Clark, Jesse; Novak, Richard; Presti, Rachel; Gulick, Roy (Trip)

doi:10.1016/s2352-3018(23)00200-x

The Lancet HIV

2023

DOI: 10.1016/s2352-3018(23)00200-x

|View full text |Cite

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

Mark A Marzinke,

Brett Hanscom,

Zhe Wang

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

HIV Pre-Exposure Prophylaxis

Liegeon,

Delaugerre,

Molina

2024

Infectious Disease Clinics of North America

View full text Add to dashboard Cite

HIV Pre-Exposure Prophylaxis

Liegeon,

Delaugerre,

Molina

2024

Infectious Disease Clinics of North America

View full text Add to dashboard Cite

Optimising oral PrEP while awaiting long-acting cabotegravir

McCormack,

Cottrell

2023

The Lancet HIV

View full text Add to dashboard Cite

How Would You Manage HIV Pre-exposure Prophylaxis in This Patient With Medical Comorbidities?

Libman,

Krakower,

Taylor

et al. 2024

Ann Intern Med

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

Cited by 3 publications

References 26 publications

HIV Pre-Exposure Prophylaxis

HIV Pre-Exposure Prophylaxis

Optimising oral PrEP while awaiting long-acting cabotegravir

How Would You Manage HIV Pre-exposure Prophylaxis in This Patient With Medical Comorbidities?

Contact Info

Product

Resources

About